Northwest Hepatobiliary Centre, University Hospital Aintree, Liverpool, UK.
Liverpool Cancer Trials Unit, University of Liverpool, Liverpool, UK.
Br J Surg. 2018 Oct;105(11):1408-1416. doi: 10.1002/bjs.10921. Epub 2018 Jul 12.
Hilar cholangiocarcinoma is staged using the AJCC staging system. Numerous other prognostically important histopathological and demographic characteristics have been reported. The objective of this meta-analysis was to assess statistically the effect of postresectional tumour characteristics on overall survival of patients undergoing attempted radical curative resection for hilar cholangiocarcinoma.
Relevant studies were identified by searching the Ovid MEDLINE and PubMed databases. The search was limited to studies published between 2009 and 2017. Papers referring to intrahepatic or distal cholangiocarcinoma were excluded from review. Data extraction used standard Parmar modifications to determine pooled univariable hazard ratios (HRs).
Twenty-four articles, containing 4599 patients, were assessed quantitatively. In pooled analyses, age (HR 1·16, 95 per cent c.i. 1·04 to 1·28), T category (HR 1·49, 1·30 to 1·70), lymph node involvement (HR 1·78, 1·65 to 1·93), microvascular invasion (HR 1·49, 1·34 to 1·68), perineural invasion (HR 1·54, 1·40 to 1·68) and tumour differentiation (HR 1·54, 1·38 to 1·72) were significant prognostic factors, with low heterogeneity. Portal vein resection (HR 1·54, 1·15 to 1·70) and resection margin status (HR 1·77, 1·57 to 1·99) had significant effects, but with high heterogeneity. Sex, tumour size and preoperative carbohydrate antigen 19-9 levels did not have a statistically significant effect on postoperative prognosis.
Several tumour biological variables not included in the seventh edition of the AJCC classification affect overall survival. These require incorporation into prognostic models to ensure a personalized approach to prognostication and treatment.
肝门部胆管癌采用 AJCC 分期系统进行分期。已经报道了许多其他具有重要预后意义的组织病理学和人口统计学特征。本荟萃分析的目的是评估术后肿瘤特征对接受根治性切除术的肝门部胆管癌患者总体生存的统计学影响。
通过检索 Ovid MEDLINE 和 PubMed 数据库来确定相关研究。搜索范围限于 2009 年至 2017 年发表的研究。从综述中排除了涉及肝内或远端胆管癌的论文。使用 Parmar 标准修改版提取数据,以确定汇总的单变量风险比(HR)。
共评估了 24 篇文章,包含 4599 例患者。在汇总分析中,年龄(HR 1.16,95%可信区间 1.04 至 1.28)、T 分期(HR 1.49,1.30 至 1.70)、淋巴结受累(HR 1.78,1.65 至 1.93)、微血管侵犯(HR 1.49,1.34 至 1.68)、神经周围侵犯(HR 1.54,1.40 至 1.68)和肿瘤分化(HR 1.54,1.38 至 1.72)是显著的预后因素,异质性低。门静脉切除术(HR 1.54,1.15 至 1.70)和切缘状态(HR 1.77,1.57 至 1.99)有显著影响,但异质性高。性别、肿瘤大小和术前癌抗原 19-9 水平对术后预后无统计学影响。
AJCC 分期第七版未包含的几种肿瘤生物学变量影响总体生存。这些因素需要纳入预后模型,以确保采用个体化方法进行预后和治疗。